ECI Appoints Taranjit S. Samra as Head of Medical Device Software Engineering, Cybersecurity and AI

ECI Appoints Taranjit S. Samra as Head of Medical DeviceSoftware Engineering, Cybersecurity and AI

Strengthens ECI's AI & Digital Transformationcapabilities to help clients develop the next generation of software-enabledmedical technologies

Marlborough, MA – [June 30, 2026] – EnhancedCompliance Inc. (ECI), a global life sciences partner delivering integratedquality, regulatory, and compliance expertise—combined with hands-onengineering execution and advanced packaging and laboratory testing—todayannounced the appointment of Taranjit S. Samra, DRSc, MSEE, RAC, as Headof Medical Device Software Engineering, Cybersecurity and AI, reporting toShital Patel, Chief Operating Officer.

"Software, cybersecurity and AI are fundamentallyreshaping the future of medical technology," said Brijesh Patel, ChiefExecutive Officer of ECI. "Taranjit brings the strong combination oftechnical depth, regulatory expertise and strategic leadership needed to helpour clients navigate this evolution with confidence. His appointmentsignificantly strengthens ECI's ability to support organizations developing thenext generation of connected, software-enabled and AI-powered medicaltechnologies."

Taranjit brings nearly 30 years of experience spanningmedical devices, diagnostics, software, digital health, AI, precision medicine,biotechnology and clinical laboratories. Throughout his career, he has helpedinnovative healthcare technology companies build quality systems and regulatoryframeworks that enable organizations to successfully commercialize emergingtechnologies while meeting increasingly complex global regulatory requirements.

His experience includes leading quality and regulatorytransformations, implementing enterprise Quality Management Systems (QMS)aligned with FDA QMSR and ISO 13485, supporting FDA Class III PMA approvals,preparing organizations for first-time FDA inspections, and developing modernapproaches to software quality, cybersecurity and AI governance. He has heldleadership roles with organizations including Verily (Google Life Sciences),Illumina, Caris Life Sciences, Tempus AI, Guardant Health, Grail, VarianMedical Systems and Sanmina-SCI.

With deep expertise in medical device software andregulatory science, Taranjit has worked closely with the FDA’s Digital Healthinitiatives, authored publications on medical device software and globalregulatory strategy, and taught graduate-level Regulatory Science. His workcontinues to help shape practical, risk-based approaches for AI-enabled qualitysystems, software engineering and regulatory compliance.

In his role at ECI, Taranjit will lead the company's MedicalDevice Software Engineering, Cybersecurity and AI practice, partnering withlife sciences organizations developing Software as a Medical Device (SaMD), Softwarein a Medical Device (SiMD), AI-enabled technologies, connected medicaldevices and digital health solutions. He will help clients navigate evolvingglobal regulatory expectations while implementing modern software engineering,cybersecurity, quality and AI governance frameworks.

His appointment further strengthens ECI's AI & DigitalTransformation solution while enhancing the company's ability to supportclients developing software-enabled medical devices, connected products,cybersecurity programs and AI-driven technologies across the entire productlifecycle.

"I'm excited to join ECI at such an important time forthe life sciences industry," said Samra. "Artificial intelligence,software and connected technologies are transforming how medical products aredeveloped, regulated and maintained throughout their lifecycle. ECI'sintegrated consulting model uniquely positions us to help organizationssuccessfully navigate this transformation while maintaining the higheststandards of quality, compliance and patient safety. I look forward to partneringwith our clients as they bring the next generation of healthcare innovation tomarket."

About ECI

Enhanced Compliance Inc. (ECI) is a global life sciencespartner delivering integrated quality, regulatory, and complianceexpertise—combined with hands-on engineering execution and advanced packagingand laboratory testing. ECI works alongside medical device, pharmaceutical,biotechnology, and combination product companies across the full productlifecycle—from development and validation through post-market andremediation—helping teams solve complex challenges, strengthen quality systemsand ensure product readiness in highly regulated environments. For more than adecade, ECI has helped life sciences companies accelerate timelines, reducerisk and bring safe, effective products to market with confidence.

‍

‍